SE0100822D0 - Method II to obtain microparticles - Google Patents
Method II to obtain microparticlesInfo
- Publication number
- SE0100822D0 SE0100822D0 SE0100822A SE0100822A SE0100822D0 SE 0100822 D0 SE0100822 D0 SE 0100822D0 SE 0100822 A SE0100822 A SE 0100822A SE 0100822 A SE0100822 A SE 0100822A SE 0100822 D0 SE0100822 D0 SE 0100822D0
- Authority
- SE
- Sweden
- Prior art keywords
- sup
- microparticles
- atp
- ase inhibitor
- obtain microparticles
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
Landscapes
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Disintegrating Or Milling (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- General Preparation And Processing Of Foods (AREA)
Priority Applications (23)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0100822A SE0100822D0 (sv) | 2001-03-09 | 2001-03-09 | Method II to obtain microparticles |
NZ527997A NZ527997A (en) | 2001-03-09 | 2002-03-06 | Method to obtain microparticles containing a H+, K+ -ATP-ase inhibitor using a fluid-bed granulation technique |
PT02701872T PT1370243E (pt) | 2001-03-09 | 2002-03-06 | Método para obter micropartículas contendo um inibidor de h+, k+-atp-ase |
CA002440163A CA2440163A1 (en) | 2001-03-09 | 2002-03-06 | Method to obtain microparticles containing a h+, k+ -atp-ase inhibitor |
DK02701872T DK1370243T3 (da) | 2001-03-09 | 2002-03-06 | Fremgangsmåde til at opnå mikropartikler, der indeholder en H+,K+-ATPase-inhibitor |
EP02701872A EP1370243B1 (en) | 2001-03-09 | 2002-03-06 | Method to obtain microparticles containing a h+, k+ -atp-ase inhibitor |
AT02701872T ATE400253T1 (de) | 2001-03-09 | 2002-03-06 | Verfahren zur gewinnung von mikropartikeln mit a h+, k+ -atp-ase-inhibitor |
DE60227488T DE60227488D1 (de) | 2001-03-09 | 2002-03-06 | Verfahren zur gewinnung von mikropartikeln mit a h+, k+ -atp-ase-inhibitor |
BR0207827-9A BR0207827A (pt) | 2001-03-09 | 2002-03-06 | Método de preparação de uma micropartìcula homogênea que compreende um inibidor de h+/k+-atpase ácido lábil, micropartìcula, composição farmacêutica, método para prevenir ou tratar uma doença relacionada com o ácido gástrico em um mamìfero, e, uso de uma micropartìcula |
US10/471,314 US20040101565A1 (en) | 2001-03-09 | 2002-03-06 | Mehtod to obtain microparticles containing a h+ k+ atp-ase inhibitor |
MXPA03007887A MXPA03007887A (es) | 2001-03-09 | 2002-03-06 | Metodo para obtener microparticulas que contienen inhibidor de h(+), k(+)-atp-asa. |
PCT/SE2002/000400 WO2002072071A1 (en) | 2001-03-09 | 2002-03-06 | Method to obtain microparticles containing a h+, k+ -atp-ase inhibitor |
ES02701872T ES2307722T3 (es) | 2001-03-09 | 2002-03-06 | Metodo para obtener microparticulas que contienen un inhibidor de n+,k+atp-asa. |
JP2002571030A JP2004522796A (ja) | 2001-03-09 | 2002-03-06 | H+,k+−atpアーゼ阻害剤を含む微粒子の製造方法 |
SI200230729T SI1370243T1 (sl) | 2001-03-09 | 2002-03-06 | Postopek za pridobivanje mikrodelcev, ki vsebujejo inhibitor H+,K+-ATPaze |
KR10-2003-7011781A KR20030081506A (ko) | 2001-03-09 | 2002-03-06 | H+, k+ -atp-아제 저해제를 함유하는 미립자의 제조방법 |
CNA028095987A CN1507343A (zh) | 2001-03-09 | 2002-03-06 | 获得含h+,k+-atp酶抑制剂的微粒的方法 |
AU2002235101A AU2002235101B8 (en) | 2001-03-09 | 2002-03-06 | Method to obtain microparticles containing A H+, K+ -ATP-ase inhibitor |
IL15746702A IL157467A0 (en) | 2001-03-09 | 2002-03-06 | Method to obtain microparticles containing a h+,k+-atp-ase inhibitor |
ZA200306614A ZA200306614B (en) | 2001-03-09 | 2003-08-25 | Method to obtain microparticles containing a H +, K + -ATP-ase inhibitor. |
NO20033966A NO20033966L (no) | 2001-03-09 | 2003-09-08 | Fremgangsmåte for oppnåelse av mikropartikler inneholdende H+, K+-ATP-ase-inhibitorer |
HK04102776A HK1059896A1 (en) | 2001-03-09 | 2004-04-20 | Method to obtain microparticles containing a h+, k+ -atp-ase inhibitor |
US11/778,298 US20080175917A1 (en) | 2001-03-09 | 2007-07-16 | Microparticles containing a H+,K+-ATP-ase inhibitor |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0100822A SE0100822D0 (sv) | 2001-03-09 | 2001-03-09 | Method II to obtain microparticles |
Publications (1)
Publication Number | Publication Date |
---|---|
SE0100822D0 true SE0100822D0 (sv) | 2001-03-09 |
Family
ID=20283293
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE0100822A SE0100822D0 (sv) | 2001-03-09 | 2001-03-09 | Method II to obtain microparticles |
Country Status (22)
Country | Link |
---|---|
US (2) | US20040101565A1 (da) |
EP (1) | EP1370243B1 (da) |
JP (1) | JP2004522796A (da) |
KR (1) | KR20030081506A (da) |
CN (1) | CN1507343A (da) |
AT (1) | ATE400253T1 (da) |
AU (1) | AU2002235101B8 (da) |
BR (1) | BR0207827A (da) |
CA (1) | CA2440163A1 (da) |
DE (1) | DE60227488D1 (da) |
DK (1) | DK1370243T3 (da) |
ES (1) | ES2307722T3 (da) |
HK (1) | HK1059896A1 (da) |
IL (1) | IL157467A0 (da) |
MX (1) | MXPA03007887A (da) |
NO (1) | NO20033966L (da) |
NZ (1) | NZ527997A (da) |
PT (1) | PT1370243E (da) |
SE (1) | SE0100822D0 (da) |
SI (1) | SI1370243T1 (da) |
WO (1) | WO2002072071A1 (da) |
ZA (1) | ZA200306614B (da) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060159756A1 (en) * | 1999-09-10 | 2006-07-20 | Brita Sjoblom | Method to obtain microparticles containing an H+,K+-ATP-ASE inhibitor |
SE0100823D0 (sv) * | 2001-03-09 | 2001-03-09 | Astrazeneca Ab | Method I to obtain microparticles |
US9700866B2 (en) | 2000-12-22 | 2017-07-11 | Baxter International Inc. | Surfactant systems for delivery of organic compounds |
US8067032B2 (en) | 2000-12-22 | 2011-11-29 | Baxter International Inc. | Method for preparing submicron particles of antineoplastic agents |
SE0100822D0 (sv) * | 2001-03-09 | 2001-03-09 | Astrazeneca Ab | Method II to obtain microparticles |
SE0100824D0 (sv) * | 2001-03-09 | 2001-03-09 | Astrazeneca Ab | Method III to obtain microparticles |
BR0212833A (pt) | 2001-09-26 | 2004-10-13 | Baxter Int | Preparação de nanopartìculas de tamanho submìcron através de dispersão e de remoção de solvente ou de fase lìquida |
US20060003012A9 (en) | 2001-09-26 | 2006-01-05 | Sean Brynjelsen | Preparation of submicron solid particle suspensions by sonication of multiphase systems |
WO2004080439A1 (ja) | 2003-03-12 | 2004-09-23 | Takeda Pharmaceutical Company Limited | 高濃度に活性成分を球形核に付着させた医薬組成物 |
DE10325989A1 (de) * | 2003-06-07 | 2005-01-05 | Glatt Gmbh | Verfahren zur Herstellung von und daraus resultierende Mikropellets sowie deren Verwendung |
US20050181052A1 (en) * | 2004-02-17 | 2005-08-18 | Patel Satishkumar A. | Lansoprazole microtablets |
WO2007095376A2 (en) * | 2006-02-15 | 2007-08-23 | Kennametal Inc. | Method and apparatus for coating particulates utilizing physical vapor deposition |
CH698658B1 (de) * | 2006-04-24 | 2009-09-30 | Mepha Ag | Orale pharmazeutische Formulierung mit schneller Freisetzung für Pyridylmethylsulfinyl-Benzimidazole. |
US20090087569A1 (en) * | 2007-09-27 | 2009-04-02 | Fenchem Enterprises Ltd. | Methods for Preparing Highly Stable Hyaluronic Acid |
IT1401284B1 (it) * | 2010-08-06 | 2013-07-18 | Valpharma S P A | Nuove formulazioni farmaceutiche idonee per la somministrazione orale di esomeprazolo magnesio diidrato, in forma di compresse mups (multi unit pellets system). |
WO2017145146A1 (en) | 2016-02-25 | 2017-08-31 | Dexcel Pharma Technologies Ltd. | Compositions comprising proton pump inhibitors |
US10076494B2 (en) | 2016-06-16 | 2018-09-18 | Dexcel Pharma Technologies Ltd. | Stable orally disintegrating pharmaceutical compositions |
JPWO2021153525A1 (da) * | 2020-01-27 | 2021-08-05 |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0163836B1 (de) * | 1984-04-07 | 1988-10-12 | Bayer Ag | Verfahren und Vorrichtung zur Herstellung von Granulaten |
IL75400A (en) * | 1984-06-16 | 1988-10-31 | Byk Gulden Lomberg Chem Fab | Dialkoxypyridine methyl(sulfinyl or sulfonyl)benzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing the same |
GB2189698A (en) * | 1986-04-30 | 1987-11-04 | Haessle Ab | Coated omeprazole tablets |
DE3909455A1 (de) * | 1989-03-22 | 1990-09-27 | Hoechst Ag | Verfahren zur herstellung von wasserdispergierbaren granulaten |
UA41946C2 (uk) * | 1994-07-08 | 2001-10-15 | Астра Актієболаг | Оральна фармацевтична складова одинична дозована форма у вигляді таблетки, спосіб її одержання, упаковка у вигляді блістера та спосіб інгібування секреції шлункової кислоти і/або лікування шлунково-кишкових запальних захворювань |
FR2725623A1 (fr) * | 1994-10-18 | 1996-04-19 | Flamel Tech Sa | Microcapsules medicamenteuses et/ou nutritionnelles pour administration per os |
DE19613395A1 (de) * | 1996-04-03 | 1997-10-09 | Basf Ag | Granulate hygroskopischer, wasserlöslicher Produkte |
DE19733094A1 (de) * | 1997-07-31 | 1999-02-04 | Merck Patent Gmbh | Formulierung auf der Basis von Ascorbinsäure mit verbesserter Farbstabilität |
DE59813833D1 (de) * | 1997-10-15 | 2007-01-11 | Merck Patent Gmbh | Herstellung eines direkt verpressbaren tablettierhilfsstoffes |
US6174548B1 (en) * | 1998-08-28 | 2001-01-16 | Andrx Pharmaceuticals, Inc. | Omeprazole formulation |
DK1037607T3 (da) * | 1997-12-08 | 2004-06-21 | Altana Pharma Ag | Hidtil ukendt suppositoriumsform, der omfatter en syrelabil aktiv forbindelse |
SE9903236D0 (sv) * | 1999-09-10 | 1999-09-10 | Astra Ab | Method to obtain microparticles |
US20060159756A1 (en) * | 1999-09-10 | 2006-07-20 | Brita Sjoblom | Method to obtain microparticles containing an H+,K+-ATP-ASE inhibitor |
SE0100823D0 (sv) * | 2001-03-09 | 2001-03-09 | Astrazeneca Ab | Method I to obtain microparticles |
SE0100824D0 (sv) * | 2001-03-09 | 2001-03-09 | Astrazeneca Ab | Method III to obtain microparticles |
SE0100822D0 (sv) * | 2001-03-09 | 2001-03-09 | Astrazeneca Ab | Method II to obtain microparticles |
-
2001
- 2001-03-09 SE SE0100822A patent/SE0100822D0/xx unknown
-
2002
- 2002-03-06 MX MXPA03007887A patent/MXPA03007887A/es active IP Right Grant
- 2002-03-06 NZ NZ527997A patent/NZ527997A/en unknown
- 2002-03-06 DE DE60227488T patent/DE60227488D1/de not_active Expired - Fee Related
- 2002-03-06 JP JP2002571030A patent/JP2004522796A/ja active Pending
- 2002-03-06 AT AT02701872T patent/ATE400253T1/de not_active IP Right Cessation
- 2002-03-06 AU AU2002235101A patent/AU2002235101B8/en not_active Ceased
- 2002-03-06 IL IL15746702A patent/IL157467A0/xx unknown
- 2002-03-06 US US10/471,314 patent/US20040101565A1/en not_active Abandoned
- 2002-03-06 WO PCT/SE2002/000400 patent/WO2002072071A1/en active IP Right Grant
- 2002-03-06 CA CA002440163A patent/CA2440163A1/en not_active Abandoned
- 2002-03-06 EP EP02701872A patent/EP1370243B1/en not_active Expired - Lifetime
- 2002-03-06 BR BR0207827-9A patent/BR0207827A/pt not_active IP Right Cessation
- 2002-03-06 KR KR10-2003-7011781A patent/KR20030081506A/ko not_active Application Discontinuation
- 2002-03-06 ES ES02701872T patent/ES2307722T3/es not_active Expired - Lifetime
- 2002-03-06 DK DK02701872T patent/DK1370243T3/da active
- 2002-03-06 SI SI200230729T patent/SI1370243T1/sl unknown
- 2002-03-06 CN CNA028095987A patent/CN1507343A/zh active Pending
- 2002-03-06 PT PT02701872T patent/PT1370243E/pt unknown
-
2003
- 2003-08-25 ZA ZA200306614A patent/ZA200306614B/xx unknown
- 2003-09-08 NO NO20033966A patent/NO20033966L/no not_active Application Discontinuation
-
2004
- 2004-04-20 HK HK04102776A patent/HK1059896A1/xx not_active IP Right Cessation
-
2007
- 2007-07-16 US US11/778,298 patent/US20080175917A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CA2440163A1 (en) | 2002-09-19 |
ES2307722T3 (es) | 2008-12-01 |
NO20033966D0 (no) | 2003-09-08 |
MXPA03007887A (es) | 2003-12-04 |
DE60227488D1 (de) | 2008-08-21 |
EP1370243A1 (en) | 2003-12-17 |
IL157467A0 (en) | 2004-03-28 |
KR20030081506A (ko) | 2003-10-17 |
BR0207827A (pt) | 2004-03-02 |
WO2002072071A1 (en) | 2002-09-19 |
ATE400253T1 (de) | 2008-07-15 |
SI1370243T1 (sl) | 2008-12-31 |
ZA200306614B (en) | 2004-11-25 |
HK1059896A1 (en) | 2004-07-23 |
AU2002235101B2 (en) | 2006-07-13 |
AU2002235101B8 (en) | 2006-08-31 |
JP2004522796A (ja) | 2004-07-29 |
PT1370243E (pt) | 2008-09-16 |
CN1507343A (zh) | 2004-06-23 |
EP1370243B1 (en) | 2008-07-09 |
US20080175917A1 (en) | 2008-07-24 |
NZ527997A (en) | 2005-02-25 |
NO20033966L (no) | 2003-11-03 |
US20040101565A1 (en) | 2004-05-27 |
DK1370243T3 (da) | 2008-10-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE0100822D0 (sv) | Method II to obtain microparticles | |
CY1107488T1 (el) | Σταθερα ξηραμενα δια ψεκασμου πρωτεϊνικα σκευασματα | |
TNSN01108A1 (en) | Oxygenated esters of 4-iodo phenylamino benzhydroxamic acids | |
EA200300171A1 (ru) | Циклопентаноиндолы, композиции, содержащие данные соединения, и способы лечения | |
RS20050066A (en) | Aqueous 2,6-diisopropylphenol pharmaceutical compositions | |
CO5580776A2 (es) | Formulacion farmaceutica estable en solucion de oxaliplatino | |
DK459486D0 (da) | Vitaminholdigt granulat, fremstilling deraf og tabletter fremstillet deraf | |
CY1106015T1 (el) | Ενα συμπυκνωμενο, υδατοδιαλυτο, κοκκωδες σκευασμα ρυθμιστη της φυτικης αναπτυξης και μεθοδοι χρησης και ιδιου | |
ATE253545T1 (de) | Biarylessigsäure-derivate und ihre verwendung als cox-2 inhibitoren | |
GR3031763T3 (en) | Novel prostaglandin synthase inhibitors | |
EA200300834A1 (ru) | Антагонисты фактора, высвобождающего кортикотропин | |
EP1247456A3 (en) | Palatable pharmaceutical compositions for companion animals | |
BR0206164A (pt) | Partìculas cristalinas de oxalato de escitalopram, método para a produção de partìculas cristalinas de oxalato de escitalopram, e, forma de dosagem unitária sólida | |
DE60238712D1 (de) | Tierstreu | |
SE0201659D0 (sv) | Modified release pharmaceutical formulation | |
BR0215175A (pt) | Métodos para a granulação úmida de azitromicina | |
NO20033967D0 (no) | Fremgangsmåte for fremstilling av mikropartikler som inneholder metoprolol | |
IL162314A (en) | Pyridine-2,4-dicarboxylic acid diamides and pyrimidine-4,6-dicarboxylic acid diamides, processes for their preparation, pharmaceutical compositions comprising them and uses thereof | |
MY135375A (en) | Pyrimidine-4,6-dicarboxylic acid diamides for selectively inhibiting collagenases | |
ATE444739T1 (de) | Polymerzusammensetzung sowie diese enthaltende darreichungsformen | |
DK1444247T3 (da) | Tibolonformuleringer | |
BR0307172A (pt) | Composição farmacêutica contendo 2,2-dicloro-12-(4-clorofenil)-ácido dodecanóico | |
NO960271D0 (no) | Tiokarbamoylforbindelser anvendt som mikrobiocider | |
ATE275401T1 (de) | Herstellung von inogatran-agglomeraten und die verbindung inogatran-anhydrid | |
RU94020112A (ru) | Премикс для собак |